Curevo Vaccine Announces $26 Million Series A1 Financing To Support Clinical Development Of Next-Generation Subunit Vaccines
Amount Raised
$26 Million
Round Type
Series A
SeattleBiotechnologyHealthcareMobileSportsPlatformsInvestors
Description
Curevo Vaccine (Curevo), a privately held clinical-stage biotechnology company dedicated to reducing the burden of infectious disease by developing safe and highly-effective vaccines, today announced the closing of a $26 million Series A1 financing round.
Quick answer
Curevo raised $26 Million in a Series A round, dated November 16, 2022. Investors: Adjuvant Capital, RA Capital Management and Janus Henderson Investors. Curevo is based in Seattle, Washington, United States.
- How much did Curevo raise?
- Curevo raised $26 Million in a Series A round on November 16, 2022.
- Who invested in Curevo?
- Adjuvant Capital, RA Capital Management and Janus Henderson Investors are named as investors in this round.
- What does Curevo do?
- Curevo is a clinical-stage biotechnology company dedicated to developing vaccines with improved tolerability and accessibility.
- Where is Curevo based and how big is it?
- Curevo is based in Seattle, Washington, United States. Fundz records about 44 employees.
- Who are the decision-makers at Curevo?
- Fundz holds 2 contacts at Curevo, including the CEO. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Healthcare and Mobile around the same time
Companies in the same sectors as Curevo that raised within 45 days of this round, from Fundz verified event records.
- Valera Health raised $45M (Private Equity) on October 31, 2022.
- Nanocan Therapeutics raised $5.1M on December 30, 2022.
- Endovia Health Sciences, Inc. raised $4M (Seed) on December 27, 2022.
- Streamex Corp. raised $1.1M (Seed) on December 21, 2022.
- Madrigal Pharmaceuticals raised $300M (Funding Round) on December 21, 2022.
- QurAlis raised $60M on December 20, 2022.
Who to call at Curevo, and when
A new round usually means Curevo is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Curevo raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Curevo, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Curevo. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Curevo raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansCurevo raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.